147 related articles for article (PubMed ID: 21245405)
1. Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye.
Choy YB; Patel SR; Park JH; McCarey BE; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2627-33. PubMed ID: 21245405
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time.
Choy YB; Park JH; McCarey BE; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4808-15. PubMed ID: 18689699
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured mucoadhesive microparticles for enhanced preocular retention.
Park CG; Kim MJ; Park M; Choi SY; Lee SH; Lee JE; Shin GS; Park KH; Choy YB
Acta Biomater; 2014 Jan; 10(1):77-86. PubMed ID: 23978409
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug.
Park CG; Kim YK; Kim MJ; Park M; Kim MH; Lee SH; Choi SY; Lee WS; Chung YJ; Jung YE; Park KH; Choy YB
J Control Release; 2015 Dec; 220(Pt A):180-188. PubMed ID: 26478018
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive Microparticles Engineered for Ophthalmic Drug Delivery.
Bin Choy Y; Park JH; Prausnitz MR
J Phys Chem Solids; 2008 May; 69(5-6):1533-1536. PubMed ID: 20657721
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response.
Anumolu SS; Singh Y; Gao D; Stein S; Sinko PJ
J Control Release; 2009 Jul; 137(2):152-9. PubMed ID: 19341773
[TBL] [Abstract][Full Text] [Related]
7. Increased partitioning of pilocarpine to the oily phase of submicron emulsion does not result in improved ocular bioavailability.
Sznitowska M; Zurowska-Pryczkowska K; Dabrowska E; Janicki S
Int J Pharm; 2000 Jul; 202(1-2):161-4. PubMed ID: 10915939
[TBL] [Abstract][Full Text] [Related]
8. Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine.
Hsiue GH; Guu JA; Cheng CC
Biomaterials; 2001 Jul; 22(13):1763-9. PubMed ID: 11396879
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive Buccal Tablets Based on Chitosan/Gelatin Microparticles for Delivery of Propranolol Hydrochloride.
Abruzzo A; Cerchiara T; Bigucci F; Gallucci MC; Luppi B
J Pharm Sci; 2015 Dec; 104(12):4365-4372. PubMed ID: 26505621
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of mucoadhesive acryloyl-quaternized PDMAEMA nanogels for ocular drug delivery.
Brannigan RP; Khutoryanskiy VV
Colloids Surf B Biointerfaces; 2017 Jul; 155():538-543. PubMed ID: 28494432
[TBL] [Abstract][Full Text] [Related]
11. Pupillary response to four concentrations of pilocarpine in normal subjects: application to testing for Adie tonic pupil.
Leavitt JA; Wayman LL; Hodge DO; Brubaker RF
Am J Ophthalmol; 2002 Mar; 133(3):333-6. PubMed ID: 11860969
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study on corneal collagen shield vehicle for delivery of pilocarpine].
Sun X; Chu R; Chen N
Zhonghua Yan Ke Za Zhi; 1996 Mar; 32(2):143-6. PubMed ID: 9206235
[TBL] [Abstract][Full Text] [Related]
13. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.
Lai JY; Hsieh AC
Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746
[TBL] [Abstract][Full Text] [Related]
14. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
[TBL] [Abstract][Full Text] [Related]
15. Polymeric pseudolatices bearing pilocarpine for controlled ocular delivery.
Vyas SP; Ramchandraiah S; Jain CP; Jain SK
J Microencapsul; 1992; 9(3):347-55. PubMed ID: 1403485
[TBL] [Abstract][Full Text] [Related]
16. Gellan gum and its methacrylated derivatives as in situ gelling mucoadhesive formulations of pilocarpine: In vitro and in vivo studies.
Agibayeva LE; Kaldybekov DB; Porfiryeva NN; Garipova VR; Mangazbayeva RA; Moustafine RI; Semina II; Mun GA; Kudaibergenov SE; Khutoryanskiy VV
Int J Pharm; 2020 Mar; 577():119093. PubMed ID: 32004682
[TBL] [Abstract][Full Text] [Related]
17. Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.
Park CG; Kim YK; Kim SN; Lee SH; Huh BK; Park MA; Won H; Park KH; Choy YB
Int J Pharm; 2017 Apr; 522(1-2):66-73. PubMed ID: 28216468
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.
Desai SD; Blanchard J
J Pharm Sci; 1998 Feb; 87(2):226-30. PubMed ID: 9519158
[TBL] [Abstract][Full Text] [Related]
19. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].
Wei J; He HL; Zheng CL; Zhu JB
Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526
[TBL] [Abstract][Full Text] [Related]
20. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
Patil S; Talele GS
Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
